Furthermore, the comprehensive PPI and molecular docking analysis showed that the six key targets (ALB, ESR1, CASP3, EGFR, JUN and TP53) related to HCC had significant binding abilities with formononetin. Here, ESR1 is linked to hepatocellular carcinoma.